Top Markets
#1 EXOD EXOD +56.80%
#2 Glidr Glidr +35.94%
#3 Fabric Protocol Fabric Protocol +24.29%
#4 Nockchain Nockchain +24.07%
#5 Bedrock Bedrock +18.12%
#6 Cysic Cysic +15.83%
#7 Perle Perle +11.41%
#8 The Black Bull The Black Bull +9.40%
#9 Arowana Arowana +7.44%
#10 Anvil Anvil +6.20%
Coin of the day
EXOD EXOD
Settings
Language
ENGLISH
Currency
USD
Theme
AXIM Biotechnologies, Inc. AXIM Biotechnologies, Inc.

AXIM Biotechnologies, Inc.

AXIM
Rank in Stocks #37613
AXIM Biotechnologies, Inc. specializes in the creation and distribution of... AXIM Biotechnologies, Inc. specializes in the creation and distribution of advanced diagnostic solutions for healthcare, focusing on critical areas such as SARS-CoV-2 (COVID-19), ocular health, and cancer treatment. The company is currently developing rapid diagnostic assays that quantify functional neutralizing antibodies, which are essential for preventing the SARS-CoV-2 virus from attaching to human cells. Additionally, it offers serological diagnostic tests designed to detect neutralizing antibodies, thereby assessing the body's adaptive immune response to the virus, and is developing tests to identify inflammation biomarkers for the effective management of COVID-19 patients. For eye health, AXIM is pioneering quick, quantitative tear tests to measure Matrix metalloproteinase-9, an inflammatory marker associated with dry eye disease. In its oncology pipeline, the firm is advancing SBI-183, an anti-metastatic compound engineered to inhibit tumor cell growth and block the spread of cancer, as well as SPX-1009, another anti-metastatic therapy aimed at determining the levels of quiescin sulfhydryl oxidase I. Established in 2010, the company was formerly known as Axim International Inc. before officially changing its name to AXIM Biotechnologies, Inc. in July 2014, and it is headquartered in San Diego, California.
Share Price
$0.0046
Last synced: 2026-08-14
Market Cap
$1.57M
Change (1 day)
-8.00%
Change (1 year)
-9.80%
Country
US
Trade AXIM Biotechnologies, Inc. (AXIM)

Category

Healthcare
Stock price history for AXIM Biotechnologies, Inc. (AXIM)
Highest end of day price: $0.00 on 2026-08-01

Lowest end of day price: $10.00 on 2014-09-01
Stock price history of AXIM Biotechnologies, Inc. from 2014 to 2026
Annual Stock Price Performance
Year Performance
2026 (TTM) -58.77%
2025 761.74%
2024 -89.76%
2023 -43.66%
2022 -89.12%
2021 -29.91%
2020 13.99%
2019 -49.55%
2018 -88.97%
2017 -12.69%
2016 1,689.26%
2015 -95.34%
2014 0.00%
Stock price for similar companies or competitors
Company Stock price Change 1y% Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $505.24 28.63%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $846.09 29.41%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $731.69 6.47%
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 $1.07K -6.40%
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $251.82 11.75%
BE